Webb2 dec. 2024 · Nabriva Therapeutics’ ordinary shares will continue to trade on the Nasdaq Global Select Market under the symbol “NBRV” and the new CUSIP number for Nabriva … Webb11 apr. 2024 · The current NBRV price target is $0.00. Learn why top analysts are making this price prediction for Nabriva Therapeutics at MarketBeat. Skip to main content. QQQ …
NBRV : Nabriva Therapeutics plc stock forecast 2024 - 2025 - 2030
Webbför 2 dagar sedan · View Nabriva Therapeutics AG NBRV investment & stock information. Get the latest Nabriva Therapeutics AG NBRV detailed stock quotes, stock data, Real … Webb🔥 Nabriva Therapeutics stock price forecast: $1; Market Cap: 5.67M, Enterprise value: N/A, P/E: -0.10, PEG ratio: N/A, EPS: -19.49, Revenue: 34.49M, EBITDA: -45 ... imperial human challenge studies
Nabriva Therapeutics plc (NBRV) Stock Forecast & Price Targets
Webb9 apr. 2024 · NASDAQ:NBRV opened at $1.75 on Friday. The stock has a market cap of $53.62 million, a price-to-earnings ratio of -0.09 and a beta of 1.56. Nabriva Therapeutics has a one year low of $1.22 and a one year high of $10.25. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.40 and a current ratio of 2.20. Webb4 aug. 2024 · In the last trading session, 1.42 million Nabriva Therapeutics plc (NASDAQ:NBRV) shares changed hands as the company’s beta touched 1.83. With the company’s per share price at $1.22 changed hands at $0.06 or 5.29% during last session, the market valuation stood at $60.78M. NBRV’s last price wa WebbAmbev traded at $2.80 this Friday March 31st, decreasing $0.07 or 2.44 percent since the previous trading session. Looking back, over the last four weeks, Ambev lost 8.53 percent. Over the last 12 months, its price fell by 14.89 percent. Looking ahead, we forecast Ambev to be priced at 2.54 by the end of this quarter and at 2.28 in one year, according to … imperial how to print